ask="12.25"
ask_size="900"
average_daily_volume="9845"
bid="N/A"
bid_size="N/A"
book_value="2.91"
change="+0.17"
change_from_200_day_moving_average="-0.79"
change_from_50_day_moving_average="-0.97"
change_from_52_week_high="-4.78"
change_From_52_week_low="1.95"
change_in_percent="+1.88%"
close="9.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.64"
ebitda="0.00"
eps_estimate_current_year="-1.99"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-1.85"
ex_dividend_date="N/A"
float_shares="3574000"
high="9.73"
high_52_weeks="13.98"
last_trade_date="2/24/2017"
last_trade_price="9.20"
last_trade_size="100"
last_trade_time="4:00pm"
low="9.16"
low_52_weeks="7.25"
market_capitalization="85.28M"
moving_average_200_day="9.99"
moving_average_50_day="10.17"
name="Gemphire Therapeutics Inc."
notes="N/A"
one_year_target_price="19.75"
open="9.68"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-7.95%"
percent_change_from_50_day_moving_average="-9.57%"
percent_change_from_52_week_high="-34.19%"
percent_change_from_52_week_low="+26.90%"
previous_close="9.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.10"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9270000"
short_ratio="0.73"
stock_exchange="NGM"
symbol="GEMP"
volume="6357"
weeks_range_52="7.25 - 13.98"
